These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33239138)

  • 1. Predictors of the usefulness of mirogabalin for neuropathic pain: a single-institution retrospective study.
    Kanbayashi Y; Amaya F; Ikoma K; Ueno H; Tabuchi Y; Ishikawa T; Takayama K; Taguchi T
    Pharmazie; 2020 Nov; 75(11):602-605. PubMed ID: 33239138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic effects of the novel α₂δ ligand mirogabalin in a rat model of spinal cord injury.
    Domon Y; Kitano Y; Makino M
    Pharmazie; 2018 Nov; 73(11):659-661. PubMed ID: 30396385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study.
    Vinik A; Rosenstock J; Sharma U; Feins K; Hsu C; Merante D;
    Diabetes Care; 2014 Dec; 37(12):3253-61. PubMed ID: 25231896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study.
    Tetsunaga T; Tetsunaga T; Nishida K; Misawa H; Takigawa T; Yamane K; Tsuji H; Takei Y; Ozaki T
    J Orthop Surg Res; 2020 May; 15(1):191. PubMed ID: 32456647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies.
    Kato J; Baba M; Kuroha M; Kakehi Y; Murayama E; Wasaki Y; Ohwada S
    Clin Ther; 2021 May; 43(5):822-835.e16. PubMed ID: 34059327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic effects of mirogabalin, a novel ligand for α
    Saeki K; Yasuda SI; Kato M; Kano M; Domon Y; Arakawa N; Kitano Y
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):723-728. PubMed ID: 30770951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic effects of the novel α
    Murasawa H; Kobayashi H; Saeki K; Kitano Y
    Psychopharmacology (Berl); 2020 Jan; 237(1):189-197. PubMed ID: 31515584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double-blind, placebo-controlled phase III study in Asian patients.
    Baba M; Matsui N; Kuroha M; Wasaki Y; Ohwada S
    J Diabetes Investig; 2019 Sep; 10(5):1299-1306. PubMed ID: 30672128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirogabalin activates the descending noradrenergic system by binding to the α
    Oyama M; Watanabe S; Iwai T; Tanabe M
    J Pharmacol Sci; 2021 May; 146(1):33-39. PubMed ID: 33858653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study.
    Merante D; Rosenstock J; Sharma U; Feins K; Hsu C; Vinik A;
    Pain Med; 2017 Nov; 18(11):2198-2207. PubMed ID: 28371941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers.
    Jansen M; Warrington S; Dishy V; Ohwada S; Johnson L; Brown K; Ishizuka H
    Clin Pharmacol Drug Dev; 2018 Aug; 7(6):661-669. PubMed ID: 29663714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure-response modeling of average daily pain score, and dizziness and somnolence, for mirogabalin (DS-5565) in patients with diabetic peripheral neuropathic pain.
    Hutmacher MM; Frame B; Miller R; Truitt K; Merante D
    J Clin Pharmacol; 2016 Jan; 56(1):67-77. PubMed ID: 26073181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of a new voltage-gated Ca
    Kato J; Inoue T; Yokoyama M; Kuroha M
    Expert Opin Pharmacother; 2021 Dec; 22(17):2311-2322. PubMed ID: 34431423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coadministration of probenecid and cimetidine with mirogabalin in healthy subjects: A phase 1, randomized, open-label, drug-drug interaction study.
    Tachibana M; Yamamura N; Atiee GJ; Hsu C; Warren V; He L; Dishy V; Zahir H
    Br J Clin Pharmacol; 2018 Oct; 84(10):2317-2324. PubMed ID: 29920736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of coadministration of metformin with mirogabalin: Results from a phase 1, randomized, open-label, drug-drug interaction study
.
    Dow J; Currie A; He L; Zaidi F; Zahir H
    Int J Clin Pharmacol Ther; 2018 Oct; 56(10):451-458. PubMed ID: 30049303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of mirogabalin and pregabalin in Japanese patients with neuropathic pain: a retrospective cohort study.
    Nakajima R; Ooba N; Kamei M; Hashiba H; Miyazaki C
    Expert Opin Drug Saf; 2023; 22(9):841-848. PubMed ID: 36945742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open-Label Single-Dose Study to Assess the Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics of Mirogabalin.
    Duchin K; Senaldi G; Warren V; Marbury T; Lasseter K; Zahir H
    Clin Drug Investig; 2018 Nov; 38(11):1001-1009. PubMed ID: 30171457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of mirogabalin in Asian patients with diabetic peripheral neuropathic pain.
    Baba M; Matsui N; Kuroha M; Wasaki Y; Ohwada S
    J Diabetes Investig; 2020 May; 11(3):693-698. PubMed ID: 31722446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP study.
    Miyazaki T; Matsumoto K; Sato T; Sano I; Furukawa K; Shimoyama K; Kamohara R; Suzuki M; Kondou M; Ikeda N; Tabata S; Shiosakai K; Nagayasu T;
    BMC Cancer; 2024 Jan; 24(1):80. PubMed ID: 38225552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the dose titration and adherence of mirogabalin in patients with peripheral neuropathic pain depending on renal function: a nationwide electronic medical record database study.
    Kato K; Kodama S; Shiosakai K; Kimura T
    Expert Opin Pharmacother; 2023 Feb; 24(2):267-282. PubMed ID: 36503333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.